Weight-loss drugs: what are the benefits and risks?
Our podcast guest discusses weight-loss drugs such as Wegovy and Mounjaro and the additional health benefits they can bring – as well as the potential risks and what nurses need to know when caring for patients who are using them. Lisa Rickers, a registered nurse with more than 15 years’ experience as a bariatric specialist in the NHS, says the health benefits extend far beyond shedding excess pounds. Mounjaro has become available in general practice for the first time.
Our podcast discusses what nurses need to know about Wegovy and Mounjaro, as the latter becomes available in general practice for the first time
Popularity of weight-loss drugs means nurses need to keep their knowledge updated
The mass rollout of weight-loss drugs on the NHS in England began this week as GPs became able to prescribe the drugs for the first time. Some 220,000 people with the ‘greatest need’ are expected to receive Mounjaro, the commercial name for tirzepatide, over the next three years.
In this episode of the Nursing Standard podcast, Lisa Rickers – a registered nurse with more than 15 years’ experience as a bariatric specialist in the NHS – explains that the health benefits of these drugs extend far beyond shedding excess pounds. She also discusses their potential risks, and offers advice for nurses when caring for patients who are using them.
Follow the Nursing Standard podcast on Apple Podcasts, Spotify, Acast or wherever you get your podcasts.
Listen to more Nursing Standard podcasts
New advanced nursing practice principles: what can you expect?
This podcast discusses expectations of nursing at advanced level
Nurse leadership tips: how to develop your skills
RCN Nursing Leadership Academy’s Emily McWhirter explores issues including conflict resolution
Diabetes and menopause: how their symptoms can overlap
Why certain menopause symptoms can be confused with having low blood sugar
